SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 18th, 2023 • RVL Pharmaceuticals PLC • Pharmaceutical preparations • New York
Contract Type FiledAugust 18th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 15, 2023, between RVL Pharmaceuticals plc, an Irish incorporated public limited company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 12th, 2023 • SEALSQ Corp • Semiconductors & related devices
Contract Type FiledJuly 12th, 2023 Company IndustryThis Securities Purchase Agreement (this “Agreement”) is dated as of July 11, 2023, between SEALSQ CORP, a British Virgin Islands company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 4th, 2023 • Addex Therapeutics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledApril 4th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April 3, 2023, between Addex Therapeutics Ltd, a société anonyme organized under the laws of Switzerland (the “Company”), and the purchaser identified on the signature pages hereto (the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 26th, 2022 • Addex Therapeutics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJuly 26th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 22, 2022, between Addex Therapeutics Ltd, a société anonyme organized under the laws of Switzerland (the “Company”), and the purchaser identified on the signature pages hereto (the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 11th, 2022 • Stealth BioTherapeutics Corp • Pharmaceutical preparations • New York
Contract Type FiledApril 11th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of April 10, 2022, is between Stealth BioTherapeutics Corp, a Cayman Islands exempted company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 28th, 2022 • Ucommune International LTD • Services-business services, nec • New York
Contract Type FiledJanuary 28th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of , 2022, between Ucommune International Ltd, a Cayman Islands exempted company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 14th, 2021 • Hudson Capital Inc. • Services-management consulting services • New York
Contract Type FiledDecember 14th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of December 13, 2021, between Hudson Capital, Inc., a British Virgin Islands company (the “Company”), and ATW Opportunities Master Fund L.P. (the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 28th, 2017 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJuly 28th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July [__, 2017, between Rosetta Genomics Ltd., an Israeli company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).